This NDC is on FDA's drug shortage list (posted Nov 3, 2017)
Product Information
MORPHINE SULFATE 4 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.3174 per ML under NDC 00641612525. Its NADAC has been published 116 times since Apr 17, 2024.
FDA first approved this application on May 21, 2015. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641612525
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205758FDA Approved
5/21/2015
TE Code
AP
On Market Since
6/3/2015
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE 4 MG/ML VIAL has been published 116 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3174 per ML |
|---|---|
| All-time high | $2.3362 (Aug 14, 2024) |
| All-time low | $2.2766 (Feb 19, 2025) |
| 52-week high | $2.3174 |
| 52-week low | $2.2766 |
| Median price | $2.2820 |
| Average price | $2.2922 |
| Largest weekly change | -1.4% (Sep 18, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Morphine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE 4 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE 4 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.3174 per ML (NDC 00641612525), effective Sep 30, 2026.
How has the price of MORPHINE SULFATE 4 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE 4 MG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 116 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE 4 MG/ML VIAL?
Since Apr 17, 2024, the NADAC for MORPHINE SULFATE 4 MG/ML VIAL has ranged from a low of $2.2766 (Feb 19, 2025) to a high of $2.3362 (Aug 14, 2024), with a median of $2.2820 per ML.
Are there cheaper alternatives to MORPHINE SULFATE 4 MG/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE 4 MG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE 4 MG/ML VIAL?
MORPHINE SULFATE 4 MG/ML VIAL (NDC 00641612525) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is MORPHINE SULFATE 4 MG/ML VIAL in shortage?
Yes — NDC 00641612525 is currently listed in FDA's drug shortage database (posted Nov 3, 2017).